Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 14/20 | 0.40 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2932725 | 1.00 | TAS1R3 (0.42) | TAS1R3TAS1R1TAS1R2PTK2LRRK2 | |
| SCHEMBL2931691 | 0.96 | TAS1R3 (0.45) | TAS1R3TAS1R1TAS1R2PTK2LRRK2 | |
| SCHEMBL1760905 | 0.88 | TAS1R3 (0.43) | TAS1R3TAS1R1TAS1R2PTK2LRRK2 | |
| SCHEMBL1760984 | 0.88 | TAS1R3 (0.43) | TAS1R3TAS1R1TAS1R2PTK2LRRK2 | |
| SCHEMBL1760925 | 0.87 | TAS1R3 (0.47) | TAS1R3TAS1R1TAS1R2PTK2LRRK2 | |
| SCHEMBL2931938 | 0.86 | PIK3CD (0.37) | PIK3CDPIK3CA | |
| SCHEMBL3047619 | 0.84 | RIPK1 (0.37) | PIK3CDPIK3CA | |
| SCHEMBL2931313 | 0.84 | LRRK2 (0.38) | LRRK2PIK3CDPIK3CA | |
| SCHEMBL2931742 | 0.79 | MEN1 (0.38) | — | |
| SCHEMBL1760927 | 0.79 | SCD (0.40) | TAS1R3TAS1R1TAS1R2LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2027132-B1 | THIAZOLO-PYRAMIDINE / PYRIDINE UREA DERIVATIVES AS ADENOSINE A2B RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2010-09-15 | — | — | EP | claimed |